Sanome are building a human digital twin to detect health changes as early as possible, based on combination biomarkers. To enable this, we have developed a multi-modal biomarker platform for data collection and an AI-tool that identifies combination biomarkers that can be turned into clinically actionable diagnostics. We are now looking to develop selected partnerships that have a need for multi-modal biomarker collection (digital, device and lab-based) and are interested in jointly developing diagnostics / prognostics based on combination biomarkers.
More about Sanome here: https://sanome.com/